在RBM15依赖的m6A修饰中介于非小细胞肺癌细胞的进展
Man Wang1, Yujiao Qin1, Xiaoqi Ai1
1Department of Respiratory Medicine, The First Affiliated Hospital of Jilin University, 1 Xinmin Street, Changchun, 130021, Jilin, China.
Molecular medicine (Cambridge, Mass.)
|December 23, 2024
概括
这项研究表明,RBM15通过调节m6A修饰来促进非小细胞肺癌 (NSCLC) 的进展. 准RBM15为NSCLC治疗提供了一个潜在的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 非小细胞肺癌 (NSCLC) 是全球癌症相关死亡的主要原因.
- RNA结合蛋白15 (RBM15) 在NSCLC发病过程中的作用,特别是它对N6-甲基氨酸 (m6A) 修饰的参与,仍未得到充分研究.
研究的目的:
- 研究RBM15在NSCLC进展中的功能性作用.
- 阐明NSCLC中RBM15介导的m6A修饰的潜在分子机制.
主要方法:
- 定量实时PCR (RT-qPCR) 和西部抹杀用于评估RBM15,KLF1,TRIM13和ANXA8的表达.
- 细胞增殖,入侵和迁移试验 (CCK-8,殖民地形成,Transwell) 来评估RBM15的功能影响.
- RNA免疫沉降 (RIP) 和m6A特异性免疫沉降 (MeRIP) 试验用于探索分子相互作用和m6A水平.
- 乌比基测定和体内异种移植/转移模型以确认发现.
主要成果:
- 在NSCLC组织和细胞中,RBM15显著过度表达.
- RBM15的敲除抑制了NSCLC细胞的增殖,入侵和迁移.
- 通过YTHDF1/YTHDF2介导的m6A修饰,RBM15上调调节了KLF1和下调调节了TRIM13,促进了ANXA8的表达.
- 过度表达ANXA8抵消了RBM15沉默对NSCLC恶性瘤的抑制作用.
- 在体内研究证实,RBM15的下调抑制了NSCLC的生长和转移.
结论:
- 通过增强KLF1和通过m6A修饰抑制TRIM13,RBM15促进NSCLC的进展,导致ANXA8表达的增加.
- RBM15-KLF1-TRIM13-ANXA8轴代表了NSCLC的一个新的调节途径.
- 准RBM15为NSCLC治疗提供了一个潜在的治疗策略.
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
01:22MicroRNAs
21.2K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
01:22PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
01:20The Retinoblastoma Gene
4.0K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.0K